CANVIVA™ To Sponsor Arcview International Cannabis Investor Forum
Arcview Held July 17-19 in Chicago Brings Together Cannabis Operators And Investors
Minnetonka, MN – July 19, 2019—CANVIVA™ of Minnetonka announces that they are a Platinum Sponsor at the Arcview International Cannabis Forum being held July 17-19 at the Fairmont, Chicago. The Arcview Group brings together accredited investors with cannabis companies. CANVIVA co-founders Jim Zimmerman and Dave Rye will serve as industry experts at the forum. They will deliver both presentations and panel discussions.
CANVIVA recently launched a new line of cannabidiol (CBD) products. CBD is derived from industrial hemp—the non-intoxicating plant in the cannabis family. The initial launch of CANVIVA includes 10 functional tinctures (drops taken under the tongue), a pet product, and two topical products, which are applied to the skin.
Providing Operators And Investors Opportunities To Learn About What Is Shaping The Cannabis Industry
The Arcview International Investor Forum will provide an opportunity to learn about themes and issues shaping the cannabis industry. Forum speakers are prominent industry leaders, providing fresh insights and up-to-date market intelligence. Attendees also have chances to hear pitches from early-to-growth stage companies. In addition, they can engage in one-on-one meetings. Sessions include: CBD & Hemp Challenges & Opportunities, Building a Winning Cannabis Brand, Cannabis Investment Opportunities and Obstacles, and others. A full listing can be found here: Arcview Event Schedule.
Jim Zimmerman and Dave Rye are consumer packaged good veterans who founded CANVIVA in January 2019 after the Farm Bill passed in December 2018 paving the way for the legalization of industrial hemp and CBD. The CBD market has since exploded—projected to grow to over $22 billion by 2022. CANVIVA’s mission is to become the most recognizable and trusted CBD brand in the U.S., the go-to resource for inspiration, education, and provider of the highest quality CBD products available. CANVIVA advances this mission by focusing on CBD tinctures.
“We are excited to partner with Arcview and to share our insights and learnings from working in the CBD space,” said CANVIVA co-founder Dave Rye. “The CBD market has been referred to as the ‘wild west’—consumers and retailers are appropriately concerned about the quality and safety of CBD. Through CANVIVA, we are delivering badly needed education, along with product quality and transparency the industry needs,” continued Rye.
“As the gold standard for effectiveness, CBD tinctures align with our company mission to deliver products that benefit consumers the most,” said CANVIVA co-founder, Jim Zimmerman. “Our research team will continue to identify essential oils and plant terpenes that deliver additional benefits for specific needs and conditions and continually expand the CANVIVA product line,” continued Zimmerman.
Arcview attendees can connect with CANVIVA co-founders Rye and Zimmerman at the Forum.
About CANVIVA And The Arcview Group
About CANVIVA™: CANVIVA offers superior quality PURE CERTIFIED CBD™ Oil products, including tinctures, topical products, and a pet tincture. CANVIVA is the trusted, go-to CBD brand for inspiration and education. From soil to certification, CANVIVA products are made with phytocannabinoid rich, full spectrum cannabinoid (CBD) oil from hemp that is organically grown in the U.S. and formulated to support a variety of health concerns to help consumers be the best you. www.CANVIVA.com.
About The Arcview Group: The Arcview Group has been connecting cannabis investors with public as well as private cannabis companies for nearly a decade. Eaze, Tokyo Smoke, Anandia Labs, Zynerba, MedMen, CanvasRX, 4Front, MJ Freeway, Ebbu, Mjardin, and many more notable companies presented at Arcview long before they made headlines. Based in the Bay area, Arcview’s market research reports are the #1 cited source in the space with the 7th edition of their flagship report, The State of Legal Cannabis Markets, recently launched.